CXCL13 levels are elevated in patients with Waldenstrom macroglobulinemia, and are predictive of major response to ibrutinib.

ABSTRACT:

SUBMITTER: Vos JM 

PROVIDER: S-EPMC5664407 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature